Octreotide Impurity 12 is a related peptide species formed during octreotide synthesis or degradation. Modifications in residue sequence or protecting-group history alter ring conformation and retention times. Researchers employ it as a reference to refine impurity limits and analytical sensitivity. Applications include QC method validation, stability testing, and structural-variant comparison.
CAT No: R2763
Synonyms/Alias:(R)-1-((2R,3R)-2-((4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamido)-3-hydroxybutoxy)-1-oxopropan-2-yl (R)-2-hydroxypropanoate; L-Lactolactoyl-Thr-Octreotide; Octreotide Impurity 12
Octreotide Impurity 12 is a specialized carbohydrate-related compound commonly encountered as a byproduct during the synthesis and analysis of octreotide, a well-known cyclic octapeptide analog. With its unique structural attributes, Octreotide Impurity 12 plays a significant role in research environments, particularly those concerned with peptide synthesis, analytical method development, and pharmaceutical impurity profiling. Its presence and identification are essential for ensuring the accuracy and reliability of peptide-based studies, as even trace levels of such impurities can influence the interpretation of experimental results. As a reference standard, Octreotide Impurity 12 supports the advancement of analytical techniques and quality assurance procedures within the broader field of peptide research.
Analytical Method Development: Octreotide Impurity 12 serves as a vital reference standard for the development and optimization of analytical methods, including high-performance liquid chromatography (HPLC) and mass spectrometry (MS). Researchers utilize this impurity to establish the specificity, sensitivity, and selectivity of their analytical protocols, ensuring that octreotide and its related substances can be accurately separated, detected, and quantified. By incorporating this impurity into method validation studies, laboratories can assess the robustness and reliability of their analytical systems, which is critical for quality control and regulatory documentation in pharmaceutical research.
Peptide Synthesis Optimization: In the context of synthetic peptide production, the presence of Octreotide Impurity 12 provides valuable insight into the efficiency and fidelity of the synthetic process. By monitoring and characterizing this impurity, chemists can identify potential side reactions, incomplete couplings, or deprotection steps that may occur during solid-phase peptide synthesis. This information enables the refinement of synthesis protocols, leading to improved yields, higher purity products, and reduced formation of undesired byproducts, ultimately supporting the development of more efficient and scalable manufacturing processes.
Pharmaceutical Impurity Profiling: The identification and quantification of Octreotide Impurity 12 are crucial for comprehensive impurity profiling in pharmaceutical research. Understanding the impurity landscape of peptide-based drug candidates allows scientists to assess the potential impact of these substances on product stability, efficacy, and safety. Through systematic analysis, researchers can establish impurity thresholds, track changes during formulation development, and ensure the consistency of peptide preparations across different production batches, contributing to overall product quality assurance.
Stability Studies: The inclusion of Octreotide Impurity 12 in stability-indicating studies enables researchers to evaluate the degradation pathways and shelf-life of octreotide formulations. By simulating storage and handling conditions, scientists can monitor the formation and progression of impurities over time, gaining a deeper understanding of the factors that influence peptide stability. This knowledge informs the selection of optimal storage conditions, packaging materials, and formulation strategies, ultimately supporting the long-term preservation of peptide therapeutics and research materials.
Structural Characterization and Reference Standardization: Octreotide Impurity 12 is frequently employed in structural elucidation studies using advanced spectroscopic and chromatographic techniques. Its well-defined structure allows researchers to calibrate instruments, validate peak assignments, and confirm the identity of related substances within complex mixtures. By serving as a benchmark for structural analysis, this impurity enhances the accuracy and reproducibility of research findings, facilitating the comparison of results across laboratories and supporting collaborative efforts in peptide science.
Quality Control in Research Reagents: The application of Octreotide Impurity 12 extends to the quality assessment of research-grade reagents and intermediates used in peptide synthesis and analytical workflows. By detecting and quantifying trace levels of this impurity, laboratories can verify the integrity and consistency of their materials, reducing the risk of experimental variability and ensuring the reliability of downstream applications. This capability is especially important in high-throughput research settings, where reproducibility and data integrity are paramount for advancing scientific discovery and innovation.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.